70 related articles for article (PubMed ID: 3102137)
1. Low red cell arachidonic acid in hemolytic uremic syndrome.
Powell HR; Groves V; McCredie DA; Yong A; Pitt J
Clin Nephrol; 1987 Jan; 27(1):8-10. PubMed ID: 3102137
[TBL] [Abstract][Full Text] [Related]
2. Low red cell arachidonic acid in cyclosporine-treated patients.
Phair PG; Powell HR; McCredie DA; Walker RG; D'Apice AJ
Clin Nephrol; 1989 Aug; 32(2):57-61. PubMed ID: 2670380
[TBL] [Abstract][Full Text] [Related]
3. Red cell membrane phospholipid abnormalities in the hemolytic uremic syndrome.
O'Regan S; Chesney RW; Kaplan BS; Drummond KN
Clin Nephrol; 1981 Jan; 15(1):14-7. PubMed ID: 7214747
[TBL] [Abstract][Full Text] [Related]
4. Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients.
Phair PG; Powell HR; McCredie DA
Transplant Proc; 1994 Dec; 26(6):3722-6. PubMed ID: 7998329
[No Abstract] [Full Text] [Related]
5. Intraplatelet serotonin (I5HT) in children with the hemolytic uremic syndrome.
Edefonti A; Bettinelli A; Mondonico P; Claris Appiani A; Picca M; Cossu MM; Tentori F; Giani M; Rossi E
Clin Nephrol; 1985 Apr; 23(4):207-11. PubMed ID: 4006329
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and membrane fluidity in erythrocytes from patients with hemolytic uremic syndrome.
Facorro G; Aguirre F; Florentin L; Díaz M; De Paoli T; Ihlo JE; Hager AA; Sánchez Avalos JC; Farach HA; Poole CP
Acta Physiol Pharmacol Ther Latinoam; 1997; 47(3):137-46. PubMed ID: 9339243
[TBL] [Abstract][Full Text] [Related]
7. Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome.
Fernández GC; Rubel C; Barrionuevo P; López L; Ramirez F; Díaz M; Isturiz MA; Palermo MS
Pediatr Nephrol; 2002 May; 17(5):337-44. PubMed ID: 12042890
[TBL] [Abstract][Full Text] [Related]
8. Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome.
Chamone DA; Proesmans WC; Monnens LA; Binda ki Muaka P; Vermylen JG
Int J Pediatr Nephrol; 1982 Mar; 3(1):13-6. PubMed ID: 7049977
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
Tinaztepe K; Akkök N; Tinaztepe B
Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
[TBL] [Abstract][Full Text] [Related]
10. 6-keto-PGF1 alpha levels and prostacyclin therapy in 2 adult patients with hemolytic-uremic syndrome.
Hautekeete ML; Nagler JM; Cuykens JJ; Parizel G; Laekeman GM; Herman AG
Clin Nephrol; 1986 Sep; 26(3):157-9. PubMed ID: 3533335
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell Thomsen-Friedenreich antigen expression and galectin-3 plasma concentrations in Streptococcus pneumoniae-associated hemolytic uremic syndrome and hemolytic anemia.
Burin des Roziers N; Chadebech P; Bodivit G; Guinchard E; Bruneel A; Dupré T; Chevret L; Jugie M; Gallon P; Bierling P; Noizat-Pirenne F
Transfusion; 2015 Jun; 55(6 Pt 2):1563-71. PubMed ID: 25556575
[TBL] [Abstract][Full Text] [Related]
12. [Pattern of serum and red cell electrolytes in acute haemolytic uraemic syndrome (author's transl)].
Diekmann L; Bonzel KE; Koch H
Klin Padiatr; 1980 Nov; 192(6):526-32. PubMed ID: 7194393
[TBL] [Abstract][Full Text] [Related]
13. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.
Ferraris JR; Ramirez JA; Ruiz S; Caletti MG; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET
Pediatr Nephrol; 2002 Oct; 17(10):809-14. PubMed ID: 12376808
[TBL] [Abstract][Full Text] [Related]
14. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal pneumonia with empyema and hemolytic uremic syndrome in children: report of three cases.
Lee CF; Liu SC; Lue KH; Chen JP; Sheu JN
J Microbiol Immunol Infect; 2006 Aug; 39(4):348-52. PubMed ID: 16926983
[TBL] [Abstract][Full Text] [Related]
16. T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia.
Huang DT; Chi H; Lee HC; Chiu NC; Huang FY
Pediatr Infect Dis J; 2006 Jul; 25(7):608-10. PubMed ID: 16804430
[TBL] [Abstract][Full Text] [Related]
17. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
Shiraishi M; Ichiyama T; Matsushige T; Iwaki T; Iyoda K; Fukuda K; Makata H; Matsubara T; Furukawa S
J Neuroimmunol; 2008 May; 196(1-2):147-52. PubMed ID: 18410971
[TBL] [Abstract][Full Text] [Related]
18. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
[TBL] [Abstract][Full Text] [Related]
19. Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives.
Túri S; Beattie TJ; Belch JJ; Murphy AV
Clin Nephrol; 1986 Apr; 25(4):193-8. PubMed ID: 3516482
[TBL] [Abstract][Full Text] [Related]
20. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
Kamitsuji H; Nonami K; Murakami T; Ishikawa N; Nakayama A; Umeki Y
Clin Nephrol; 2000 May; 53(5):319-24. PubMed ID: 11305804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
